Accuray Fixing The Margins, But Where's The Growth?

Healthcare Sector and Stocks Analysis from Seeking Alpha

Thu, 9 Feb 2012

By Stephen Simpson : Med-tech companies don't fix themselves overnight, but Accuray ( ARAY ) management deserves real praise for how quickly it has addressed one of the biggest challenges of the TomoTherapy acquisition. That said, the overall system growth for this company is not yet where it needs ...

Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha

Related Topics:

Related Videos

Don't Expect Transformational M&A Deals in 2012

Thu, 19 Jan 2012

There is room for smaller, tuck-in acquisitions this year, but blockbluster deals are likely off the table for a few years, says Morningstar's Bridget Freas.

Content Partners

Site Directory Site Map Our Products

Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News

International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K.

Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2010 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Russell 2000 quote is 10 minutes delayed.